Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CA9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma

CA9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma

US Patent 8778608 · Granted Jul 15, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for treating cancer2020
Fusion molecule based on TAA variant2019
Kidney-specific tumor vaccine directed against kidney tumor antigen G-2502018
Fusion molecule based on novel TAA variant2018
Fusion molecule based on novel TAA variant2016
Kidney-specific tumor vaccine directed against kidney tumor antigen G-2502016
Fusion molecule based on novel TAA variant2016
Methods of renal cell carcinoma prognosis and treatment selection with carbonic 2015
Kidney specific tumor vaccine directed against kidney tumor antigen G-2502014
Fusion molecule based on novel TAA variant2013
Kidney-specific tumor vaccine directed against kidney tumor antigen G-2502009
Chimeric transcriptional regulatory element compositions and methods for increas2007